Showing results (71-80 of 85) with videos related to
Sort By:
Pageof 9
Journal of the American Society of Hypertension : JASH|September 1, 2015
Baseline characteristics of African Americans in the Systolic Blood Pressure Intervention TrialCarolyn H Still, Timothy E Craven, Barry I Freedman, et al.Clinical Transplants|August 19, 2015
Highly Sensitized Patients: Miami Transplant Institute ExperienceAdela D Mattiazzi, Alexandra Centeno, Alexandra Amador, et al.Hypertension (Dallas, Tex. : 1979)|November 23, 2012
A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney diseaseMahboob Rahman, Tom Greene, Robert A Phillips, et al.Archives of Internal Medicine|April 30, 2008
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African AmericansLawrence J Appel, Jackson T Wright, Tom Greene, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 1, 2012
Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKDFrancis B Gabbai, Mahboob Rahman, Bo Hu, et al.Journal of the American Society of Nephrology : JASN|July 21, 2019
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINTSrinivasan Beddhu, Jincheng Shen, Alfred K Cheung, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 25, 2016
Non-GFR Determinants of Low-Molecular-Weight Serum Protein Filtration Markers in CKDXun Liu, Meredith C Foster, Hocine Tighiouart, et al.The Lancet. Rheumatology|February 1, 2024
Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trialEliza F Chakravarty, Tammy Utset, Diane L Kamen, et al.The New England Journal of Medicine|September 8, 2010
Intensive blood-pressure control in hypertensive chronic kidney diseaseLawrence J Appel, Jackson T Wright, Tom Greene, et al.Pharmacogenetics and Genomics|October 25, 2021
Contribution of APOA5, APOC3, CETP, ABCA1 and SIK3 genetic variants to hypertriglyceridemia development in Mexican HIV-patients receiving antiretroviral therapyJonathan Saúl Bautista-Martínez, José Antonio Mata-Marín, Jorge Luis Sandoval-Ramírez, et al.Pageof 9